Lilly Oncology on Canvas Invites Entries

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 15 No 3
Volume 15
Issue 3

Eli Lilly and Company and the National Coalition for Cancer Survivorship have issued a call for entries for the 2006 Lilly Oncology on Canvas: Expressions of a Cancer Journey International Art Competition and Exhibition.

INDIANAPOLIS—Eli Lilly and Company and the National Coalition for Cancer Survivorship have issued a call for entries for the 2006 Lilly Oncology on Canvas: Expressions of a Cancer Journey International Art Competition and Exhibition. The competition invites people diagnosed with any type of cancer, their families and friends, cancer advocates, and health care providers, as well as artists and art students, to express, through art and narrative, their own cancer journeys. Art entries will be accepted through July 30, 2006, in the following media: oil, watercolor, acrylic, pastel, photography, and other one-dimensional art. Winners of the 2004 competition can be viewed at www.lilly.com. For additional contest details and to obtain a registration form, please call 1-800-734-4131 or contact Anita Chernewski, art director, at achernewski@cprworldwideusa.com.

Recent Videos
Historical standards for H3 K27M-mutant diffuse midline glioma treatment may harm healthy central nervous system cells, according to Ashley L. Sumrall, MD.
2 experts are featured in this series.
1 expert is featured in this series.
2 experts are featured in this series.
Dordaviprone was recommended at a dose of 625 mg orally once weekly for adults, and the recommended dosage is based on body weight for pediatric patients.
Extended follow-up for individuals with H3 K27M-mutated diffuse midline glioma may help explain the duration of response across patient subgroups.